Development
Biodesix, Inc.
BDSX
$0.3029
$0.02117.49%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 55.06% | 20.07% | 15.60% | -19.99% | -53.12% |
| Total Depreciation and Amortization | -20.72% | -25.54% | 5.35% | 30.05% | 92.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -63.06% | -15.25% | -53.07% | 37.94% | 151.12% |
| Change in Net Operating Assets | -1,304.65% | 181.15% | 1,445.53% | 483.04% | 339.91% |
| Cash from Operations | -2.80% | 62.85% | 109.77% | 41.32% | -17.17% |
| Capital Expenditure | -54.61% | -651.87% | -1,850.46% | -2,829.77% | -264.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 70.18% | -7.89% | -7.84% | 66.67% | 48.65% |
| Cash from Investing | -51.03% | -621.84% | -1,603.16% | -2,089.20% | -209.98% |
| Total Debt Issued | -66.67% | -- | -- | -- | -- |
| Total Debt Repaid | 99.94% | 99.40% | 99.60% | -9.09% | -17.81% |
| Issuance of Common Stock | -69.27% | 661.49% | -99.44% | -77.29% | 154.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 82.96% | -47.32% | 45.54% | 40.96% | -757.65% |
| Cash from Financing | -48.08% | 636.51% | -110.53% | 14.57% | 1,059.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -76.91% | 118.13% | -164.68% | -9.38% | 283.63% |